Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevenar (13v) Infant Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

NCT02119104 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02119104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02119104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevenar (13v) Infant Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 31, 2014
Completion date
May 31, 2016
Enrollment
1,087 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infants